ARCHIVES

Mayo Clinic Study Finds Samarium May Expand Options For Osteosarcoma

This article is from The Cancer Letter archive.

Vol. 25 No. 2 | February 22, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Moves to Regulate Lab-Developed Tests

August 1, 2014

NCI Plans $61 Million For Six-Year Program In Biomarker Research For Early Detection

December 4, 1998

DCT Board Oks Recompetition Of Master Agreement For BRM Trials

February 4, 1983

Oral Complications Reduced By Pretherapy NIH Conference Finds

April 28, 1989

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

August 27, 2004

House Bill Gives NCI $135 Million Increase, NIH $846 Million for FY 1988 Over 1987 Budgets

August 7, 1987